PMID- 28191674 OWN - NLM STAT- MEDLINE DCOM- 20180718 LR - 20180731 IS - 1600-0625 (Electronic) IS - 0906-6705 (Linking) VI - 26 IP - 10 DP - 2017 Oct TI - Induced histamine regulates Ni elution from an implanted Ni wire in mice by downregulating neutrophil migration. PG - 868-874 LID - 10.1111/exd.13315 [doi] AB - Histamine regulates various inflammatory reactions. We have reported that the expression of histidine decarboxylase (HDC) was induced by subcutaneous implantation of nickel (Ni) wire. However, the source and functions of histamine in Ni elution and Ni wire-induced inflammation have not been completely studied. We aimed to elucidate the effects of de novo synthesized histamine on leucocyte infiltration and Ni elution. Implantation of Ni wire induced an increase in the Ni ion content of the surrounding tissues and serum and in the mRNA levels of HDC, a histamine-producing enzyme, macrophage inflammatory protein-2 (MIP-2), a chemoattractant for neutrophils, and monocyte chemoattractant protein-1 (MCP-1), a chemoattractant for monocytes. The Ni wire induced HDC expression even in mast cell-deficient WBB6F1-W/W(V) mice. In HDC knockout (HDC KO) mice, the Ni wire-induced increase in MIP-2 mRNA expression was significantly higher than that in wild-type mice but not MCP-1. MIP-2 expression was enhanced in histamine H2 receptor knockout (H2R KO) mice but not in WBB6F1-W/W(V) mice. Histamine inhibited NiCl(2) -induced MIP-2 mRNA expression in mouse bone marrow-derived macrophages (BMDMs) obtained from wild-type mice; this inhibition was not observed in BMDMs from H2R KO mice. Ni elution increased in HDC KO mice, in which leucocyte infiltration also increased, and was suppressed in mice treated with neutrophil-specific antibody. These results suggest that the Ni wire induced HDC expression in non-mast cells and that, in the chronic phase of inflammation, endogenous histamine reduced Ni elution, probably through regulation of MIP-2 expression and neutrophil migration. CI - (c) 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. FAU - Kishimoto, Yu AU - Kishimoto Y AUID- ORCID: 0000-0002-8876-0500 AD - Laboratory of Pharmacotherapy of Life-style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. FAU - Asakawa, Sanki AU - Asakawa S AD - Laboratory of Pharmacotherapy of Life-style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. FAU - Sato, Taiki AU - Sato T AD - Laboratory of Pharmacotherapy of Life-style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. FAU - Takano, Takayuki AU - Takano T AD - Laboratory of Pharmacotherapy of Life-style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. FAU - Nakajyo, Takahisa AU - Nakajyo T AD - Laboratory of Pharmacotherapy of Life-style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. FAU - Mizuno, Natsumi AU - Mizuno N AD - Laboratory of Pharmacotherapy of Life-style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. FAU - Segawa, Ryosuke AU - Segawa R AD - Laboratory of Pharmacotherapy of Life-style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. FAU - Yoshikawa, Takeo AU - Yoshikawa T AD - Department of Pharmacology, Graduate School of Medicine, Tohoku University, Sendai, Japan. FAU - Hiratsuka, Masahiro AU - Hiratsuka M AD - Department of Pharmacology, Graduate School of Medicine, Tohoku University, Sendai, Japan. FAU - Yanai, Kazuhiko AU - Yanai K AD - Department of Pharmacology, Graduate School of Medicine, Tohoku University, Sendai, Japan. FAU - Ohtsu, Hiroshi AU - Ohtsu H AD - Department of Quantum Science and Energy Engineering, Graduate School of Engineering, Tohoku University, Sendai, Japan. FAU - Hirasawa, Noriyasu AU - Hirasawa N AD - Laboratory of Pharmacotherapy of Life-style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. LA - eng PT - Journal Article DEP - 20170503 PL - Denmark TA - Exp Dermatol JT - Experimental dermatology JID - 9301549 RN - 0 (Ccl2 protein, mouse) RN - 0 (Chemokine CCL2) RN - 0 (Chemokine CXCL2) RN - 0 (Cxcl2 protein, mouse) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Histamine H2) RN - 696BNE976J (nickel chloride) RN - 7OV03QG267 (Nickel) RN - 820484N8I3 (Histamine) RN - EC 4.1.1.22 (Histidine Decarboxylase) SB - IM MH - Animals MH - *Cell Movement MH - Cells, Cultured MH - Chemokine CCL2/genetics/metabolism MH - Chemokine CXCL2/genetics/metabolism MH - Down-Regulation MH - Gene Expression/drug effects MH - Histamine/*metabolism/pharmacology MH - Histidine Decarboxylase/genetics/metabolism MH - Inflammation/etiology/genetics/*metabolism MH - Macrophages/drug effects MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Neutrophils/*physiology MH - Nickel/adverse effects/*metabolism/pharmacology MH - Prostheses and Implants MH - RNA, Messenger/*metabolism MH - Receptors, Histamine H2/genetics OTO - NOTNLM OT - H2 receptor OT - histidine decarboxylase OT - leukocyte OT - macrophage inflammatory protein-2 OT - metal implant EDAT- 2017/02/14 06:00 MHDA- 2018/07/19 06:00 CRDT- 2017/02/14 06:00 PHST- 2017/02/02 00:00 [accepted] PHST- 2017/02/14 06:00 [pubmed] PHST- 2018/07/19 06:00 [medline] PHST- 2017/02/14 06:00 [entrez] AID - 10.1111/exd.13315 [doi] PST - ppublish SO - Exp Dermatol. 2017 Oct;26(10):868-874. doi: 10.1111/exd.13315. Epub 2017 May 3.